HLA-E and systemic sclerosis: We took advantage of a phenotypically well-defined sample of 46 SSc patients before and after AHSCT to retrospectively analyze the influence of the HLA-E and HLA-G circulating expression levels and genetic diversity on the observed clinical responses at different time points during follow-up after AHSCT for SSc.